Ваш мозг. Что нейронаука знает о мозге и его причудах

¹¹ E.A. Osuch, T.A. Ketter, T.A. Kimbrell, M.S. George, B.E. Benson, M.W. Willis, P. Herscovitch, and R.M. Post, “Regional Cerebral Metabolism Associated with Anxiety Symptoms in Affective Disorder Patients,” Biological Psychiatry 48, no. 10 (November 2000): 1020–1023.

^12. Mayberg et al., “Reciprocal Limbic-Cortical Function and Negative Mood,” 675–682.

^13. T. Hajek, J. Kozeny, M. Kopecek, M. Alda, and C. Hoschl, “Reduced Subgenual Cingulate Volumes in Mood Disorders: A MetaAnalysis,” Journal of Psychiatry & Neuroscience 33, no. 2 (March 2008): 91–99.

^14. D.L. Dunner, A.J. Rush, J.M. Russell, M. Burke, S. Woodard, P. Wingard, and J. Allen, “Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients with TreatmentResistant Depression,” Journal of Clinical Psychiatry 67 (2006): 688–695.

^15. M.T. Berlim, A. McGirr, F. Van den Eynde, M.P. Fleck, and P. Giacobbe, “Effectiveness and Acceptability of Deep Brain Stimulation (DBS) of the Subgenual Cingulate Cortex for TreatmentResistant Depression: A Systematic Review and Exploratory Meta-Analysis,” Journal of Affective Disorders 159 (April 2014): 31–38.

^16. K.S. Choi, P. Riva-Posse, R.E. Gross, and H.S. Mayberg, “Mapping the ‘Depression Switch’ during Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation,” JAMA Neurology 72, no. 11 (November 2015): 1252–1260.

^17. Там же.

^18. B.H. Bewernick, S. Kayser, V. Sturm, and T.E. Schlaepfer, “LongTerm Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy,” Neuropsychopharmacology 37, no. 9 (August 2012): 1975–1985.

^19. J.L. Price and W.C. Drevets, “Neural Circuits Underlying the Pathophysiology of Mood Disorders,” Trends in Cognitive Sciences 16, no. 1 (January 2012): 61–71.

^20. G.M. Cooney, K. Dwan, C.A. Greig, D.A. Lawlor, J. Rimer, ER. Waugh, M. McMurdo, and G.E. Mead, “Exercise for Depression,” The Cochrane Database of Systematic Reviews 12, no. 9 (September 2013): CD004366.

²¹ Цит. по: F. Lopez-Munoz and C. Alamo, “Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today,” Current Pharmaceutical Design 15 (2009): 1563–1586.

^22. E. Shorter, A History of Psychiatry: From the Era of the Asylum to the Age of Prozac (New York: John Wiley & Sons, Inc., 1997).

^23. National Center for Health Statistics, “Health, United States, 2010: With Special Feature on Death and Dying,” 2011 Feb. Report, 2011.

^24. P.D. Kramer, Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self (New York: Penguin Books, 1993).

^25. R. Invernizzi, C. Velasco, M. Bramante, A. Longo, and R. Samanin, “Effect of 5-HT1A Receptor Antagonists on Citalopram-Induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus,” Neuropharmacology 36, no. 4–5 (1997): 467–473.

^26. G.R. Heninger, P.L. Delgado, and D.S. Charney, “The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings from Monoamine Depletion Experiments in Humans,” Pharmacopsychiatry 29, no. 1 (1996): 2-11.

^27. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson, “Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration,” PLoS Medicine 5, no. 2 (2008): e4. Важно отметить, что данная тема неоднозначна и работа авторов была во многом раскритикована. Результаты исследования были опубликованы в 2008 г., и впоследствии появились свидетельства как в поддержку, так и в опровержение полученных в его ходе результатов. Даже в тех исследованиях, которые подтверждают эффективность антидепрессантов, уточняется, что их воздействие на пациента очень ограничено.

²⁸ X. Wang, L. Zhang, Y. Lei, X. Liu, X. Zhou, Y. Liu, M. Wang, et al., “Meta-Analysis of Infectious Agents and Depression,” Scientific Reports 4 (2014): 4530.

^29. M. Lucas, F. Mirzaei, A. Pan, O.I. Okereke, W.C. Willett, E.J. O’Reilly, K. Koenen, and A. Ascherio, “Coffee, Caffeine, and Risk of Depression among Women,” Archives of Internal Medicine 171, no. 17 (September 2011): 1571–1578.

^30. H. Hedegaard, S.C. Curtin, and M. Warner, “Suicide Mortality in the United States, 1999–2017,” NCHS Data Brief 330 (November 2018): 1–7.

Глава 6

^1. J. Cole, Pride and a Daily Marathon (Massachusetts: The MIT Press, 1991).

^2. G. Fritsch and E. Hitzig, “Electric Excitability of the Cerebrum (Uber die elektrische Erregbarkeit des Grosshirns),” Epilepsy & Behavior 15, no. 2 (June 2009): 123–130.

^3. M. Omrani, M.T. Kaufman, N.G. Hatsopoulos, and P.D. Cheney, “Perspectives on Classical Controversies about the Motor Cortex,” Journal of Neurophysiology 118, no. 3 (September 2017): 1828–1848.